AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavretsky, H.
Right arrow Articles by Vinters, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavretsky, H.
Right arrow Articles by Vinters, H. V.
Am J Geriatr Psychiatry 8:257-261, August 2000
© 2000 American Association for Geriatric Psychiatry


Brief Report

Apolipoprotein-E and White-Matter Hyperintensities in Late-Life Depression

Helen Lavretsky, M.D., Ira M. Lesser, M.D., Marcy Wohl, R.N., Bruce L. Miller, M.D., C. Marc Mehringer, M.D., and Harry V. Vinters, M.D.

Received May 18, 1999; revised November 15, 1999; accepted November 23, 1999. From the UCLA School of Medicine, Department of Psychiatry. Address correspondence to Dr. Lavretsky, UCLA–Neuropsychiatric Institute, Room 37-425, 760 Westwood Pl., Los Angeles CA 90024.

The authors conducted a follow-up study of 16 patients with late-life depression approximately 6 years after their initial assessment to evaluate the relationships between apolipoprotein-E (APO-E) status and white-matter hyperintensities (WMH). Ten patients had WMH at baseline, and four patients demonstrated an increase in WMH size over time. Three of four patients with the APO-E {epsilon}4 allele demonstrated an increase in WMH over time, and only 1 of 12 patients without an {epsilon}4 allele had an increase in WMH. Three of four patients with APO-E {epsilon}4 allele developed a chronic course of major depression at follow-up. Patients with APO-E {epsilon}4 had a higher number of depressive episodes and lower age at onset. APO-E may be a risk factor for cerebrovascular disease associated with late-life depression and may affect the clinical characteristics and disease course of depression.

Key Words: Dementias • MRI • White-Matter Hyperintensities




This article has been cited by other articles:


Home page
AJGPHome page
Y.-C. Yen, G. W. Rebok, J. J. Gallo, M.-J. Yang, F.-W. Lung, and C.-H. Shih
ApoE4 Allele Is Associated With Late-Life Depression: A Population-Based Study
Am J Geriatr Psychiatry, October 1, 2007; 15(10): 858 - 868.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
H. Lavretsky, L. Ercoli, P. Siddarth, S. Bookheimer, K. Miller, and G. Small
Apolipoprotein {epsilon}4 Allele Status, Depressive Symptoms, and Cognitive Decline in Middle-Aged and Elderly Persons Without Dementia
Am J Geriatr Psychiatry, December 1, 2003; 11(6): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
D. G. Blazer, B. B. Burchett, and G. G. Fillenbaum
APOE {epsilon}4 and Low Cholesterol as Risks for Depression in a Biracial Elderly Community Sample
Am J Geriatr Psychiatry, October 1, 2002; 10(5): 515 - 520.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
H. Lavretsky and A. Kumar
Clinically Significant Non-Major Depression: Old Concepts, New Insights
Am J Geriatr Psychiatry, June 1, 2002; 10(3): 239 - 255.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2000 American Association for Geriatric Psychiatry